CHARLOTTE BALLARD: Open Payments
NPI 1902893324 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$770 in 39 payments from 8 companies in 2025. Trend: 2023 $1,560 · 2024 $994 · 2025 $770
Food & beverage: $770
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 19 | $293 |
| E.R. Squibb & Sons, L.L.C. | 7 | $216 |
| Neurocrine BioSciences, Inc. | 4 | $76 |
| Teva Pharmaceuticals USA, Inc. | 2 | $55 |
| Otsuka America Pharmaceutical, Inc. | 3 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Janssen Pharmaceuticals, Inc | 1 | $22 |
| Lilly USA, LLC | 1 | $18 |
Products named: COBENFY, LYBALVI, ARISTADA, INGREZZA, AUSTEDO XR, REXULTI, CAPLYTA, INVEGA SUSTENNA.
Industry payments across TX — which companies pay providers there.
